Obesity Pharmacotherapy in Patients With Type 2 Diabetes

IN BRIEF Patients with obesity and type 2 diabetes are key targets for weight loss. Given the lack of behavioral weight loss in most patients, obesity pharmacotherapy options should be considered in this patient population. This article reviews key pharmacotherapy options for patients with coexistin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahan, Scott, Fujioka, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
From Research to Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687110/
https://www.ncbi.nlm.nih.gov/pubmed/29151715
http://dx.doi.org/10.2337/ds17-0044
Descripción
Sumario:IN BRIEF Patients with obesity and type 2 diabetes are key targets for weight loss. Given the lack of behavioral weight loss in most patients, obesity pharmacotherapy options should be considered in this patient population. This article reviews key pharmacotherapy options for patients with coexisting obesity and type 2 diabetes. Diabetes medications that are associated with weight gain should be avoided in these patients if possible.

Ejemplares similares